Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec;14(6):1117-1124.
doi: 10.1007/s12265-021-10115-x. Epub 2021 Mar 11.

TMA/TMAO in Hypertension: Novel Horizons and Potential Therapies

Wan-Qin Zhang  1 , Yun-Jiao Wang  1 , Ao Zhang  2 , Yue-Jia Ding  1 , Xiao-Nan Zhang  1 , Qiu-Jin Jia  1 , Ya-Ping Zhu  1 , Yan-Yang Li  3 , Shi-Chao Lv  4 , Jun-Ping Zhang  1
Affiliations
Review

TMA/TMAO in Hypertension: Novel Horizons and Potential Therapies

Wan-Qin Zhang et al. J Cardiovasc Transl Res. 2021 Dec.

Abstract

Hypertension is the most prevalent chronic disease and a risk factor for various diseases. Although its mechanisms and therapies are constantly being updated and developed, they are still not fully clarified. In recent years, novel gut microbiota and its metabolites have attracted widespread attention. It is strongly linked with physiological and pathological systems, especially TMA and TMAO. TMA is formed by intestinal microbial metabolism of choline and L-carnitine and converted into TMAO by FMO3. This paper collected and collated the latest researches and mainly discussed the following four parts. It introduced gut microbiota; provided a focus on TMA, TMA-producing bacteria, and TMAO; summarized the alternations in hypertensive patients and animals; discussed the mechanisms of TMAO with two respects; and summarized the regulatory factors may be as new interventions and therapies of hypertension. And, more relevant studies are still prospected to be accomplished between hypertension and TMA/TMAO for further clinical services.

Keywords: Gut microbiota; Hypertension; Inflammation; TMA; TMAO.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. GBD. (2015). Risk Factors Collaborators (2016) Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388, 1659–1724. https://doi.org/10.1016/S0140-6736(16)31679-8 . - DOI
    1. Lawes, C. M., Vander Hoorn, S., & Rodgers, A. (2008). International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet, 371, 1513–1518. https://doi.org/10.1016/S0140-6736(08)60655-8 . - DOI - PubMed
    1. Whelton, P. K., Carey, R. M., & Aronow, W. S. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension, 71, e13–e115. https://doi.org/10.1161/HYP.0000000000000065 . - DOI - PubMed
    1. Writing Group Members, Mozaffarian, D., Benjamin, E. J., & Go, A. S. (2016). Stroke Statistics Subcommittee. Executive Summary: Heart Disease and Stroke Statistics—2016 Update: A report from the American Heart Association. Circulation, 133, 447–454. https://doi.org/10.1161/CIR.0000000000000366 . - DOI
    1. Norlander, A. E., Madhur, M. S., & Harrison, D. G. (2018). The immunology of hypertension. The Journal of Experimental Medicine, 215, 21–33. https://doi.org/10.1084/jem.20171773 . - DOI - PubMed

Publication types

LinkOut - more resources